Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mori, N.
Right arrow Articles by Yamamoto, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mori, N.
Right arrow Articles by Yamamoto, N.
Related Collections
Right arrow Neoplasia
Right arrow Gene Expression
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 95 No. 12 (June 15), 2000: pp. 3915-3921

Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells

Naoki Mori, Masahiro Fujii, Kousuke Iwai, Shuichi Ikeda, Yoshihiro Yamasaki, Tomoko Hata, Yasuaki Yamada, Yuetsu Tanaka, Masao Tomonaga, and Naoki Yamamoto

From the Department of Preventive Medicine and AIDS Research, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan; Department of Laboratory Medicine, Nagasaki University School of Medicine, Nagasaki, Japan; Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine, Nagasaki, Japan; Department of Internal Medicine, City of Sasebo General Hospital, Sasebo, Japan; Department of Internal Medicine, Kokura Memorial Hospital, Kitakyushu, Japan; Department of Infectious Disease and Immunology, Okinawa-Asia Research Center of Medical Science, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Virology, Niigata University School of Medicine, Niigata, Japan.

Human T-cell leukemia virus type-I (HTLV-I) is the etiologic agent of adult T-cell leukemia (ATL). This study examined the status of the oncogenic transcription factor AP-1 in leukemic cells freshly isolated from patients with ATL. Leukemic cells from peripheral blood of all patients with ATL exhibited constitutive AP-1 DNA binding activity, whereas mononuclear cells from normal individuals did not. In agreement with previous studies, HTLV-I transforming protein, Tax, was found to stimulate the DNA binding activity of AP-1 in a T-cell line. However, HTLV-I genes, including Tax, were not significantly expressed in leukemic cells freshly obtained from patients with ATL. Moreover, all T-cell lines derived from leukemic cells of patients with ATL also displayed constitutive AP-1 DNA binding activity, but expressed little Tax protein. Thus, leukemic cells of patients with ATL appear to have Tax-independent mechanisms that induce AP-1 activity, both in vivo and in vitro. In antibody supershift experiments, AP-1 in fresh leukemic cells and ATL-derived cell lines were found to contain JunD. Consistently, all primary ATL cells and ATL-derived cell lines expressed high levels of JunD messenger RNA. Our results suggest that AP-1 is activated in leukemic cells of patients with ATL through a Tax-independent mechanism and this may play a role in the deregulated phenotypes of ATL leukemic cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Mizuguchi, H. Asao, T. Hara, M. Higuchi, M. Fujii, and M. Nakamura
Transcriptional Activation of the Interleukin-21 Gene and Its Receptor Gene by Human T-cell Leukemia Virus Type 1 Tax in Human T-cells
J. Biol. Chem., September 18, 2009; 284(38): 25501 - 25511.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Isono, T. Ohshima, Y. Saeki, J. Matsumoto, M. Hijikata, K. Tanaka, and K. Shimotohno
Human T-cell Leukemia Virus Type 1 HBZ Protein Bypasses the Targeting Function of Ubiquitination
J. Biol. Chem., December 5, 2008; 283(49): 34273 - 34282.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Bellon and C. Nicot
Regulation of Telomerase and Telomeres: Human Tumor Viruses Take Control
J Natl Cancer Inst, January 16, 2008; 100(2): 98 - 108.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Brown, M. Bellon, and C. Nicot
Emodin and DHA potently increase arsenic trioxide interferon-{alpha}-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1
Blood, February 15, 2007; 109(4): 1653 - 1659.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-M. Mesnard, B. Barbeau, and C. Devaux
HBZ, a new important player in the mystery of adult T-cell leukemia
Blood, December 15, 2006; 108(13): 3979 - 3982.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. Grant, P. Jain, M. Nonnemacher, K. E. Flaig, B. Irish, J. Ahuja, A. Alexaki, T. Alefantis, and B. Wigdahl
AP-1-directed human T cell leukemia virus type 1 viral gene expression during monocytic differentiation
J. Leukoc. Biol., September 1, 2006; 80(3): 640 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-M. Peloponese Jr. and K.-T. Jeang
Role for Akt/Protein Kinase B and Activator Protein-1 in Cellular Proliferation Induced by the Human T-cell Leukemia Virus Type 1 Tax Oncoprotein
J. Biol. Chem., March 31, 2006; 281(13): 8927 - 8938.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. Okudaira, M. Tomita, J.-N. Uchihara, T. Matsuda, C. Ishikawa, H. Kawakami, M. Masuda, Y. Tanaka, K. Ohshiro, N. Takasu, et al.
NIK-333 inhibits growth of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells in association with blockade of nuclear factor-{kappa}B signal pathway.
Mol. Cancer Ther., March 1, 2006; 5(3): 704 - 712.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Watanabe, T. Ohsugi, M. Shoda, T. Ishida, S. Aizawa, M. Maruyama-Nagai, A. Utsunomiya, S. Koga, Y. Yamada, S. Kamihira, et al.
Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-{kappa}B, as a strategy for chemoprevention and therapy of adult T-cell leukemia
Blood, October 1, 2005; 106(7): 2462 - 2471.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Mori, T. Matsuda, M. Tadano, T. Kinjo, Y. Yamada, K. Tsukasaki, S. Ikeda, Y. Yamasaki, Y. Tanaka, T. Ohta, et al.
Apoptosis Induced by the Histone Deacetylase Inhibitor FR901228 in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells
J. Virol., May 1, 2004; 78(9): 4582 - 4590.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. M. Levy, Y. Izumiya, P. Brunovskis, L. Xia, M. S. Parcells, S. M. Reddy, L. Lee, H.-W. Chen, and H.-J. Kung
Characterization of the Chromosomal Binding Sites and Dimerization Partners of the Viral Oncoprotein Meq in Marek's Disease Virus-Transformed T Cells
J. Virol., December 1, 2003; 77(23): 12841 - 12851.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. P. Szremska, L. Kenner, E. Weisz, R. G. Ott, E. Passegue, M. Artwohl, M. Freissmuth, R. Stoxreiter, H.-C. Theussl, S. B. Parzer, et al.
JunB inhibits proliferation and transformation in B-lymphoid cells
Blood, December 1, 2003; 102(12): 4159 - 4165.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Basbous, C. Arpin, G. Gaudray, M. Piechaczyk, C. Devaux, and J.-M. Mesnard
The HBZ Factor of Human T-cell Leukemia Virus Type I Dimerizes with Transcription Factors JunB and c-Jun and Modulates Their Transcriptional Activity
J. Biol. Chem., October 31, 2003; 278(44): 43620 - 43627.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Saitoh, M. Nakayama, H. Nakano, H. Yagita, N. Yamamoto, and S. Yamaoka
TWEAK Induces NF-{kappa}B2 p100 Processing and Long Lasting NF-{kappa}B Activation
J. Biol. Chem., September 19, 2003; 278(38): 36005 - 36012.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Nasr, A. Rosenwald, M. E. El-Sabban, B. Arnulf, P. Zalloua, Y. Lepelletier, F. Bex, O. Hermine, L. Staudt, H. de The, et al.
Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells
Blood, June 1, 2003; 101(11): 4576 - 4582.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Nicolaou, J. M. Teodoridis, H. Park, A. Georgakis, O. C. Farokhzad, E. P. Bottinger, N. Da Silva, P. Rousselot, C. Chomienne, K. Ferenczi, et al.
CD11c gene expression in hairy cell leukemia is dependent upon activation of the proto-oncogenes ras and junD
Blood, May 15, 2003; 101(10): 4033 - 4041.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Arnulf, A. Villemain, C. Nicot, E. Mordelet, P. Charneau, J. Kersual, Y. Zermati, A. Mauviel, A. Bazarbachi, and O. Hermine
Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis
Blood, December 1, 2002; 100(12): 4129 - 4138.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Mori, Y. Yamada, S. Ikeda, Y. Yamasaki, K. Tsukasaki, Y. Tanaka, M. Tomonaga, N. Yamamoto, and M. Fujii
Bay 11-7082 inhibits transcription factor NF-kappa B and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells
Blood, August 13, 2002; 100(5): 1828 - 1834.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020